4-Major Breakthrough in Lung Cancer Treatment Unveiled: Osimertinib's Remarkable Impact
This medication has proven to be a game-changer, demonstrating a substantial reduction in the five-year risk of recurrent cancer by an impressive 73% ...
Orpathys approved in China for patients with lung cancer and MET gene alterations
This approval follows a priority review designation by the Center for Drug Evaluation of Chinaâ€™s National Medical Products Administration (NMPA) and marks the first ...
Tagrisso approved in the US for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer
Approval based on unprecedented results from the ADAURA Phase III trial where Tagrisso reduced the risk of disease recurrence or death by 80%...
FDA Approves First Adjuvant Therapy for Most Common Type of Lung Cancer
Today, the U.S. Food and Drug Administration approved Tagrisso (osimertinib) as the first adjuvant treatment for patients with non-small cell lung cancer whose ...
Genprex receives conditional US FDA acceptance for the treatment of non-small cell lung cancer
Genprex receives conditional FDA acceptance of proprietary name REQORSA for lead drug candidate for the treatment of non-small cell lung cancer
AstraZeneca's Imfinzi granted FDA Priority Review for cancer treatment
Option would extend dosing to four weeks in non-small cell lung and bladder cancer reducing medical visits by half
Positive About COVID-19 Vaccine, Says UK Pharma Firm
AstraZeneca has already reached deals with countries to make more than 2 billion doses of its COVID-19 vaccine with Oxford Univeristy ...
Groundbreaking Data in Patients with Stage 4 Lung Cancer
AstraZeneca comes up with ground breaking data on lungs cancer...
|8 Matching result(s) found!|
|Seminar on RERA: Concerns in Real Estate heldDecember 09, 2023|
|Commonwealth youth leaders want action, not just rhetoric at COP28December 09, 2023|
|South India’s biggest Gaushala, Satyam Shivam Sundaram Gau Nivas to conduct Annakut Celebrations on Sunday on the eve of its 23rd AnniversaryDecember 08, 2023|
|Center for Diagnostics and Telemedicine Introduces Groundbreaking Service – Preliminary Clinical and Technical Testing for Medical SoftwareDecember 08, 2023|
|FTCCI to hold a Seminar on RERA: Concerns in Real EstateDecember 08, 2023|
|Adoption of Public Health Strategies and Early Detection Key for Cancer Mitigation: ExpertsDecember 08, 2023|
|Are online spaces safe for women?December 08, 2023|
|Prescribing Equality: Tackling Gender Disparities in India's Healthcare LeadershipDecember 07, 2023|
|Digitalizing Health: Generative AI's Impact Amplified by AWS Cloud in IndiaDecember 07, 2023|
|Eyes on the Future: Dr. Agarwal's Group Channels Rs 100 Crore for Cutting-edge Eye Hospitals Across KeralaDecember 06, 2023|
|Organ Transplant Scandal: Apollo Hospital Faces Government InquiryDecember 06, 2023|
|Breaking Barriers in Cancer Treatment: Max Healthcare's CAR-T Therapy PartnershipDecember 06, 2023|
|Exploring the Link Between Covid-19 Vaccination and Sudden Cardiac Arrests: ICMR StudyNovember 22, 2023|
|Powering the Future: China's Biodegradable Wireless System for Bioelectronic InnovationNovember 22, 2023|
|IMS BHU Pioneers Advanced Cardiac Care: Unveiling Cutting-Edge Technologies for Precise DiagnosisNovember 18, 2023|
|Inito's $6 Million Boost: Transforming Women's Health with AI-Backed Fertility MonitoringNovember 18, 2023|
|Madras High Court Advocates for Equality: PG Medical Students to Receive Incentive Marks for COVID-19 DutyNovember 18, 2023|
|Next-Gen Healthcare: CarePods and AI Redefine the Patient ExperienceNovember 17, 2023|
|Air Quality Crisis: Alarming Rise in Premature Births Linked to Air Quality in Begusarai, BiharNovember 17, 2023|
|Limerick Contest-2023: A Celebration of Wit and PoetryNovember 17, 2023|